Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Mylan Institutional LLC

NDC labeler codes: 67457, 72078

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

152Products (NDC)

Prescription medicines

Show the other 26 medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
ApprovedApplicationMedicineSponsor
July 28, 2026ANDA213915 Sugammadex
SUGAMMADEX SODIUM
Mylan
June 25, 2026ANDA212572 Ferric carboxymaltose
FERRIC CARBOXYMALTOSE
Mylan Labs Ltd
June 25, 2026ANDA217076 Ferric carboxymaltose
FERRIC CARBOXYMALTOSE
Mylan
June 25, 2026ANDA217769 Ferric carboxymaltose
FERRIC CARBOXYMALTOSE
Mylan
August 19, 2025ANDA217877 Paclitaxel
PACLITAXEL
Mylan
August 8, 2025ANDA212559 Iron sucrose
IRON SUCROSE
Mylan Labs Ltd
June 30, 2025ANDA212967 Amphotericin b
AMPHOTERICIN B
Mylan Labs Ltd
June 23, 2025ANDA219084 Meropenem
MEROPENEM
Brooks Steriscience
June 12, 2024ANDA213913 Epoprostenol
EPOPROSTENOL SODIUM
Mylan
December 26, 2023ANDA211500 Posaconazole
POSACONAZOLE
Mylan Labs Ltd
October 26, 2023ANDA206091 Ropivacaine hydrochloride
ROPIVACAINE HYDROCHLORIDE
Mylan Labs Ltd
August 7, 2023ANDA213966 Daptomycin
DAPTOMYCIN
Mylan
November 2, 2022ANDA212567 Triamcinolone acetonide
TRIAMCINOLONE ACETONIDE
Mylan Labs Ltd
June 9, 2022ANDA213843 Naloxone hydrochloride
NALOXONE HYDROCHLORIDE
Mylan Labs Ltd
August 27, 2020ANDA212571 Dexmedetomidine
DEXMEDETOMIDINE HYDROCHLORIDE
Mylan Labs Ltd
August 7, 2020ANDA213255 Acetaminophen
ACETAMINOPHEN
Mylan
September 5, 2019ANDA204015 Fosaprepitant
FOSAPREPITANT DIMEGLUMINE
Mylan Labs Ltd
April 1, 2019ANDA208137 Docetaxel
DOCETAXEL
Mylan Labs Ltd
October 25, 2018ANDA210710 Prochlorperazine
PROCHLORPERAZINE EDISYLATE
Mylan Labs Ltd
October 12, 2018ANDA210227 Medroxyprogesterone acetate
MEDROXYPROGESTERONE ACETATE
Xiromed
October 4, 2018ANDA211242 Norepinephrine bitartrate
NOREPINEPHRINE BITARTRATE
Mylan Labs Ltd
September 19, 2018ANDA206416 Palonosetron hydrochloride
PALONOSETRON HYDROCHLORIDE
Mylan Institutional
July 20, 2018ANDA203258 Eptifibatide
EPTIFIBATIDE
Mylan Labs Ltd
July 10, 2018NDA209481 Vancomycin
VANCOMYCIN HYDROCHLORIDE
Mylan Labs Ltd
July 6, 2018ANDA210848 Docetaxel
DOCETAXEL
Mylan Labs Ltd
Show the other 61 applications
ApprovedApplicationMedicineSponsor
July 2, 2018ANDA210072 Docetaxel
DOCETAXEL
Mylan Labs Ltd
June 8, 2018ANDA206608 Esmolol hydrochloride
ESMOLOL HYDROCHLORIDE
Mylan Labs Ltd
June 5, 2018ANDA205037 Daptomycin
DAPTOMYCIN
Mylan Labs Ltd
June 1, 2018ANDA202471 Bivalirudin
BIVALIRUDIN
Mylan Institutional
April 30, 2018ANDA208859 Docetaxel
DOCETAXEL
Mylan Labs Ltd
April 17, 2018ANDA210763 Sodium nitroprusside
SODIUM NITROPRUSSIDE
Mylan Labs Ltd
December 6, 2017ANDA205242 Gemcitabine
GEMCITABINE HYDROCHLORIDE
Mylan Labs Ltd
December 1, 2017BLA761074 Trastuzumab
OGIVRI
Mylan GmbH
October 27, 2017ANDA205254 Zoledronic acid
ZOLEDRONIC ACID
Mylan Labs Ltd
May 31, 2017ANDA204607 Decitabine
DECITABINE
Pharmascience Inc
May 19, 2017ANDA203800 Leucovorin calcium
LEUCOVORIN CALCIUM PRESERVATIVE FREE
Mylan Labs Ltd
May 5, 2017ANDA205833 Moxifloxacin
MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
Mylan Labs Ltd
March 31, 2017ANDA203859 Mycophenolate mofetil
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
Mylan Labs Ltd
February 14, 2017ANDA203841 Zoledronic acid
ZOLEDRONIC ACID
Mylan Labs Ltd
February 7, 2017ANDA201044 Etomidate
ETOMIDATE
Mylan Labs Ltd
September 16, 2016ANDA203308 Levetiracetam
LEVETIRACETAM
Mylan Labs Ltd
June 29, 2016ANDA205014 Naloxone hydrochloride
NALOXONE HYDROCHLORIDE
Mylan Institutional
August 18, 2014ANDA202881 Dexmedetomidine
DEXMEDETOMIDINE HYDROCHLORIDE
Mylan Institutional
June 30, 2014ANDA202626 Argatroban
ARGATROBAN
Mylan Institutional
March 28, 2014ANDA090212 Adenosine
ADENOSINE
Mylan Asi
March 6, 2014ANDA204997 Naloxone hydrochloride
NALOXONE HYDROCHLORIDE
Mylan Institutional
March 4, 2013ANDA202650 Zoledronic acid
ZOLEDRONIC ACID
Mylan Labs Ltd
August 21, 2012ANDA091406 Doxycycline
DOXYCYCLINE
Mylan Labs Ltd
August 7, 2012ANDA091358 Oxaliplatin
OXALIPLATIN
Mylan Labs Ltd
June 27, 2012ANDA201276 Cidofovir dihydrate
CIDOFOVIR
Mylan Institutional
June 25, 2012ANDA091623 Thiamine hydrochloride
THIAMINE HYDROCHLORIDE
Mylan Institutional
May 9, 2012ANDA200880 Acetazolamide
ACETAZOLAMIDE SODIUM
Mylan Asi
November 9, 2011NDA202543 Levetiracetam
LEVETIRACETAM IN SODIUM CHLORIDE
Hq Spclt Pharma
November 3, 2011ANDA091657 Tranexamic acid
TRANEXAMIC ACID
Mylan Institutional
October 28, 2011ANDA200170 Doxorubicin hydrochloride
DOXORUBICIN HYDROCHLORIDE
Mylan Labs Ltd
September 19, 2011ANDA091554 Vancomycin
VANCOMYCIN HYDROCHLORIDE
Mylan Labs Ltd
February 10, 2011ANDA079198 Octreotide acetate
OCTREOTIDE ACETATE (PRESERVATIVE FREE)
Mylan Institutional
July 20, 2010ANDA090874 Isosulfan blue
ISOSULFAN BLUE
Mylan Institutional
May 11, 2010ANDA090243 Vecuronium bromide
VECURONIUM BROMIDE
Mylan Labs Ltd
April 9, 2010ANDA091136 Granisetron
GRANISETRON HYDROCHLORIDE
Mylan Asi
April 9, 2010ANDA091137 Granisetron
GRANISETRON HYDROCHLORIDE
Mylan Asi
September 14, 2009ANDA078347 Haloperidol
HALOPERIDOL
Mylan Labs Ltd
May 13, 2009ANDA078686 Adenosine
ADENOSINE
Mylan Labs Ltd
December 30, 2008ANDA065397 Vancomycin
VANCOMYCIN HYDROCHLORIDE
Mylan Labs Ltd
December 30, 2008ANDA065432 Vancomycin
VANCOMYCIN HYDROCHLORIDE
Mylan Labs Ltd
November 26, 2008ANDA079199 Rocuronium bromide
ROCURONIUM BROMIDE
Mylan Institutional
October 31, 2008ANDA078520 Pamidronate disodium
PAMIDRONATE DISODIUM
Mylan Labs Ltd
August 29, 2008ANDA040802 Dexamethasone
DEXAMETHASONE SODIUM PHOSPHATE
Mylan Labs Ltd
August 29, 2008ANDA040803 Dexamethasone
DEXAMETHASONE SODIUM PHOSPHATE
Mylan Labs Ltd
June 25, 2008ANDA078641 Famotidine
FAMOTIDINE
Mylan Labs Ltd
June 25, 2008ANDA078642 Famotidine
FAMOTIDINE PRESERVATIVE FREE
Mylan Labs Ltd
May 22, 2008ANDA065421 Rifampin
RIFAMPIN
Mylan Labs Ltd
March 11, 2008ANDA065407 Tobramycin
TOBRAMYCIN SULFATE
Mylan Labs Ltd
March 3, 2008ANDA078639 Fomepizole
FOMEPIZOLE
Mylan Institutional
May 2, 2005ANDA076474 Esmolol hydrochloride
ESMOLOL HYDROCHLORIDE
Mylan Institutional
November 12, 2004ANDA040541 Tetradecyl hydrogen sulfate (ester)
SOTRADECOL
Mylan Institutional
October 15, 2002ANDA076217 Amiodarone hydrochloride
AMIODARONE HYDROCHLORIDE
Mylan Institutional
December 7, 2001NDA021345 Fondaparinux sodium
ARIXTRA
Mylan Ireland Ltd
August 17, 2001ANDA075918 Fluphenazine decanoate
FLUPHENAZINE DECANOATE
Mylan Labs Ltd
February 28, 2000ANDA075440 Haloperidol decanoate
HALOPERIDOL DECANOATE
Mylan Labs Ltd
October 2, 1996NDA020615 Clonidine
DURACLON
Mylan Institutional
July 12, 1996NDA020630 Remifentanil hydrochloride
ULTIVA
Mylan Institutional
May 17, 1996NDA020298 Allopurinol
ALOPRIM
Mylan
July 3, 1986NDA017808 Calcitonin salmon
MIACALCIN
Mylan Ireland Ltd
April 4, 1978NDA017788 Dimethyl sulfoxide
RIMSO-50
Mylan Institutional
August 13, 1947NDA021624 Methadone hydrochloride
METHADONE HYDROCHLORIDE
Mylan Institutional

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2026

  1. August 26, 2026 · Class II · Ongoing · D-0830-2026 · Mycophenolate mofetil

    Failed Dissolution Specifications

    Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-81. Vial Label: My

  2. July 2, 2026 · Class II · Ongoing · D-0734-2026 · Mycophenolate mofetil

    Presence of precipitate

    Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & ND

2025

  1. October 10, 2025 · Class II · Ongoing · D-0214-2026 · Haloperidol

    Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.

    Haloperidol Lactate Injection, 5 mg/mL, 25 x 1 mL Single-Dose Vials, Sterile, Rx only, For Intramuscular Use Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26605. NDC: 67457-426-12 with Safecor Health LL

2022

  1. October 7, 2022 · Class I · Terminated · D-0058-2023 · Octreotide acetate

    Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.

    Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, ND

  2. April 13, 2022 · Class II · Terminated · D-1091-2022 · Clonidine

    cGMP deviations: Temperature abuse

    Duraclon (clonidine HCl injection, USP), 1000 mcg/10 mL (100 mcg/mL), 10 mL single-dose vial, Rx only, MFG: Mylan Pharma, NDC 67457-218-10

  3. April 7, 2022 · Class II · Terminated · D-0774-2022 · Rifampin

    Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.

    Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60

2021

  1. May 3, 2021 · Class III · Terminated · D-0601-2021 · Thiamine hydrochloride

    Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.

    Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA; Manufactured by: Mylan Institu

2020

  1. August 17, 2020 · Class I · Terminated · D-1575-2020 · Amiodarone hydrochloride

    Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.

    Amiodarone Hydrochloride Injection, USP, 450 mg/9 mL (50 mg/mL), 9 mL Single-Dose Vial (NDC 67457-153-99); 10 x 9 mL Single-Dose Vials per carton (NDC 67457-153-09), Rx only, Manufactured by: Mylan Institutional, Galway,

  2. August 17, 2020 · Class I · Terminated · D-1576-2020 · Tranexamic acid

    Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.

    Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10 mL Single-Dose Vials per carton (NDC 67457-197-10), Rx only, Manufactured by: Mylan Institutional, Galway, Ire

  3. July 7, 2020 · Class I · Terminated · D-1484-2020 · Daptomycin

    Presence of Particulate Matter

    Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan Institutional, LLC, Rockford, IL 61103 USA, NDC 67457-813-50

Show the 5 older recalls

2020

  1. May 5, 2020 · Class II · Terminated · D-1271-2020 · Allopurinol

    Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.

    Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA. NDC: 67457-187-50

2019

  1. October 7, 2019 · Class II · Terminated · D-0139-2020 · Rifampin

    Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.

    Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.

2015

  1. February 18, 2015 · Class II · Terminated · D-0421-2015 · Haloperidol decanoate

    Lack of Assurance of Sterility; due to leaking vials

    Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-409-00) packaged in cartons of five (NDC 67457-409-13), Rx only, Manufactured in India for: Mylan Institutional L

  2. February 18, 2015 · Class II · Terminated · D-0422-2015 · Haloperidol decanoate

    Lack of Assurance of Sterility; due to leaking vials

    Haloperidol Decanoate Injection, 50 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-410-00) packaged in cartons of ten (NDC 67457-410-13), Rx only, Manufactured in India for: Mylan Institutional LLC

2014

  1. September 12, 2014 · Class II · Terminated · D-0005-2015 · Amiodarone hydrochloride

    Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of the distributing wholesalers.

    Amiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx only, Manufactured for Mylan Institutional, LLC, Rockford, IL 61103, NDC 67457-153-09.

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →